If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
The goal is to make our medicines available to as many people with diabetes as possible.
We cannot comment on the cost or reimbursement prospects for tirzepatide at this time. As with any potential treatment, our goal is to make our medicines available to as many people with diabetes as possible.
Date of Last Review: March 03, 2021